Posts

Is Medicine a Big Data Problem?

By Ted Driscoll / March 21, 2014 / 0 Comments

Human beings are big data. We aren’t just 175 pounds of meat and bone. We aren’t just piles of hydrogen and carbon and oxygen. What makes us all different is how it’s all organized and that is information.
We can no longer treat people based on simple numbers like weight, pulse, blood pressure, and temperature. What makes us different is much more complicated than that.

Read More

Harsh Patel Joins Claremont Creek Ventures

By Paul Straub / January 15, 2014 / 0 Comments

I’m thrilled to welcome Harsh Patel as a Partner at Claremont Creek Ventures. We believe people and relationships form the core elements of any successful entrepreneurial venture. We typically get involved early in a company’s development, when a product is nascent and a market may barely exist. One of the distinguishing characteristics about Harsh is that he excels in the same type of early-stage, relationship-oriented investing that we value.

Read More

Harveen Sethi Joins Claremont Creek Ventures as Associate

By Ted Driscoll / December 23, 2013 / 0 Comments

I am excited to announce today that Harveen Sethi has joined the CCV team as an associate. She will be working closely with Brad Webb and me. Harveen is passionate about impactful disruptive innovation, especially in shaping the next frontier of healthcare. She is particularly enthusiastic about the potential of big data analytics and technology in advancing predictive diagnostics and personalized medicine. These are […]

Read More

Ted Driscoll’s WSJ interview: 23andMe Flap With FDA Just a Bump in the Road, One Genetics-Testing Investor Says

By Claremont Creek Alerts / December 16, 2013 / 0 Comments

source:   by Timothy Hay When the Food and Drug Administration told personal-genetics company 23andMe Inc. in November to stop sending consumers detailed information about their DNA, some industry watchers said the move could be a devastating blow to an emerging area of medicine that holds promise for better health outcomes. But it was more of […]

Read More

Assurex Health Launches Collaboration with Canadian Mental Health Center

By Brad Webb / November 29, 2013 / 0 Comments

Our portfolio company Assurex Health just announced the creation of a partnership with Canada’s Center for Addiction and Mental Health (CAMH), one of the world’s leading research centers in the area of addiction and mental health and Canada’s largest mental health teaching hospital. CAMH will offer to Canadian citizens the firm’s pharmacogenomic test, GeneSight, which […]

Read More

Shotspotter’s New Technology Grabs Feature On CNN’s Erin Burnett Show

By Randy Hawks / November 26, 2013 / 0 Comments

This story about Claremont Creek Ventures’ portfolio Shotspotter covers how their new technology could improve how fast police respond to shootings inside schools and other buildings

Read More

Meet our team

Claremont Creek Ventures was founded in 2005 by Nat Goldhaber, John Steuart and Randy Hawks to pursue early stage investing in exceptional technology startups.

Nat Goldhaber

NAT GOLDHABER

Nat Goldhaber is a co-founder of Claremont Creek Ventures. 

Ted Driscoll

TED DRISCOLL

Ted is an expert on digital health and diagnostics, from big data and health technology to genomics and personalized medicine.

Paul Straub

PAUL STRAUB

Paul is particularly focused on the potential of digital and business innovation to impact and advance broad-impact industries.

Brad Webb

BRAD WEBB

Brad is focused on the role of genomics and biomarker data analytics in driving the next generation of diagnostics and drug development.

Randy Hawks

RANDY HAWKS

Randy Hawks is a co-founder of Claremont Creek Ventures.

Post Categories

Archives